Cell cycle-specific effects of lovastatin.
Lovastatin (LOV), the drug recently introduced to treat hypercholesteremia, inhibits the synthesis of mevalonic acid. The effects of LOV on the cell cycle progression of the human bladder carcinoma T24 cell line expressing activated p21ras were investigated. At a concentration of 2-10 microM, LOV ar...
Gardado en:
| Publicado en: | Proc Natl Acad Sci U S A |
|---|---|
| Principais autores: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
National Academy of Sciences
1991
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC51505/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1673788/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.88.9.3628 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|